Rejuvenating aged liver cells restores clearance of amyloid and cholesterol

Researchers have demonstrated that reversing aging in specialized liver cells—sinusoidal endothelial cells—can restore their ability to clear harmful substances from the bloodstream, including amyloid-beta (linked to Alzheimer's) and LDL cholesterol (linked to cardiovascular disease). These cells act as a critical filtration system, but their function declines dramatically with age. The study shows that rejuvenating these cells reinstates their clearance capacity, offering a potential therapeutic target for age-related diseases. This is particularly significant because it suggests that reversing cellular aging in one organ system could have downstream benefits for brain health and cardiovascular function. The liver's role as a metabolic hub means that maintaining its youthful function could have wide-ranging effects on healthspan. While the mechanisms of rejuvenation weren't fully detailed in the abstract, this proof-of-concept could open doors to interventions targeting liver endothelial aging, whether through senolytics, metabolic reprogramming, or other approaches. The dual benefit for both Alzheimer's and heart disease—two leading causes of death and disability in aging—makes this finding particularly noteworthy for translational potential.